PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

PROCEPT BioRobotics, a surgical robotics company focused on advancing patient care in urology, will be presenting at two upcoming healthcare conferences. The first presentation will be at the 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas on May 29 at 10:20 a.m. Eastern Time. The second presentation will be at the 44th Annual William Blair Growth Stock Conference in Chicago on June 4 at 5:00 p.m. Eastern Time.

The company specializes in developing transformative solutions for urology and is known for the AquaBeam Robotic System, an advanced surgical robotic system used in minimally invasive urologic surgery. This system is particularly focused on treating benign prostatic hyperplasia (BPH), a common prostate disease affecting around 40 million men in the United States. The AquaBeam Robotic System delivers Aquablation therapy, which provides effective, safe, and durable outcomes for males with lower urinary tract symptoms due to BPH.

PROCEPT BioRobotics has a strong foundation of clinical evidence, with nine clinical studies and over 150 peer-reviewed publications supporting the benefits of Aquablation therapy. The company’s goal is to improve patient care in urology through innovative robotic solutions.

For more information, interested individuals can visit the “Investors” section of the company’s website to access live webcasts of the upcoming presentations and archived recordings. Additionally, the webcasts will be available for replay for at least 90 days after the events.

For any investor inquiries, please contact Matt Bacso, VP of Investor Relations and Business Operations, at m.bacso@procept-biorobotics.com.